Indication
Still's disease
1 clinical trial
1 product
Product
EmapalumabClinical trial
A Two-cohort, Open-label, Single Arm, Multicenter Study to Evaluate Efficacy, Safety and Tolerability, PK and PD, of Emapalumab in Children and Adults With MAS in Still's Disease or With MAS in Systemic Lupus ErythematousStatus: Recruiting, Estimated PCD: 2024-09-01